CD20-directed Cytolytic Antibody [EPC]

CD20-directed Cytolytic Antibody [EPC] was reported 316949 times

Drugs of the CD20-directed Cytolytic Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5905 0.8233
1 VACCINE INTERACTION 239 0.7710
2 PEMPHIGUS 9588 0.7661
3 RED BLOOD CELL SEDIMENTATION RATE 211 0.7563
4 SWOLLEN JOINT COUNT INCREASED 2395 0.7503
5 SARS-COV-2 ANTIBODY TEST NEGATIVE 357 0.7453
6 RHEUMATIC FEVER 3322 0.7445
7 RHEUMATOID FACTOR POSITIVE 4269 0.7383
8 B-LYMPHOCYTE COUNT DECREASED 997 0.7320
9 SWOLLEN JOINT COUNT 182 0.7280
10 C-REACTIVE PROTEIN 668 0.7206
11 LUPUS VULGARIS 883 0.7008
12 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1535 0.6955
13 DEEP VEIN THROMBOSIS POSTOPERATIVE 1374 0.6860
14 DUODENAL ULCER PERFORATION 5087 0.6834
15 FACET JOINT SYNDROME 2136 0.6554
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 417 0.6243
17 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 435 0.6241
18 GRANULOMA SKIN 507 0.6175
19 MANTLE CELL LYMPHOMA RECURRENT 265 0.6092
20 B-CELL LYMPHOMA RECURRENT 329 0.6059
21 HAND DEFORMITY 7884 0.6005
22 BLOOD PRESSURE DIASTOLIC ABNORMAL 1527 0.5998
23 LYMPHOMA TRANSFORMATION 214 0.5944
24 HUMORAL IMMUNE DEFECT 220 0.5930
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 1417 0.5728
26 JC POLYOMAVIRUS TEST POSITIVE 667 0.5696
27 X-RAY ABNORMAL 988 0.5520
28 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1140 0.5497
29 HELICOBACTER INFECTION 5257 0.5110
30 DISLOCATION OF VERTEBRA 1157 0.5068
31 SYNOVITIS 8962 0.4965
32 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 470 0.4963
33 C-REACTIVE PROTEIN ABNORMAL 3152 0.4909
34 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 267 0.4759
35 MUSCLE INJURY 3848 0.4639
36 FOLLICULAR LYMPHOMA 406 0.4614
37 RETINITIS 777 0.4494
38 FOLLICULITIS 4499 0.4286
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2772 0.4264
40 BLOOD IMMUNOGLOBULIN M DECREASED 427 0.4257
41 PERIPHERAL VENOUS DISEASE 1705 0.4171
42 BLOOD PARATHYROID HORMONE DECREASED 588 0.3965
43 PERICARDITIS 6456 0.3839
44 GLOSSODYNIA 8562 0.3820
45 GRANULOMATOSIS WITH POLYANGIITIS 451 0.3737
46 HYPOGAMMAGLOBULINAEMIA 2403 0.3654
47 DRUG TOLERANCE DECREASED 1002 0.3565
48 NEUROLOGIC NEGLECT SYNDROME 197 0.3543
49 BONE EROSION 1254 0.3542
50 CONTRAINDICATED PRODUCT ADMINISTERED 10607 0.3500
51 MANTLE CELL LYMPHOMA 482 0.3165
52 BLOOD IMMUNOGLOBULIN A DECREASED 201 0.3088
53 RHEUMATOID NODULE 835 0.3029
54 HEPATITIS B REACTIVATION 959 0.3019
55 SERONEGATIVE ARTHRITIS 345 0.3010
56 VACCINATION FAILURE 496 0.2981
57 PANNICULITIS 703 0.2903
58 SYSTEMIC LUPUS ERYTHEMATOSUS 9959 0.2803
59 CENTRAL NERVOUS SYSTEM LYMPHOMA 380 0.2756
60 BLOOD IMMUNOGLOBULIN G DECREASED 683 0.2754
61 OVERLAP SYNDROME 190 0.2714
62 BREAST CANCER STAGE III 1738 0.2681
63 WOUND 7492 0.2678
64 DIFFUSE LARGE B-CELL LYMPHOMA 2042 0.2647
65 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 608 0.2637
66 IMMUNOGLOBULINS DECREASED 362 0.2635
67 NEUROMYELITIS OPTICA SPECTRUM DISORDER 352 0.2609
68 INFUSION RELATED REACTION 16734 0.2522
69 EAR PRURITUS 880 0.2507
70 CAROTID ARTERY THROMBOSIS 211 0.2485
71 PORPHYRIA ACUTE 352 0.2453
72 JC VIRUS INFECTION 385 0.2406
73 GRIP STRENGTH DECREASED 2118 0.2404
74 LIP DRY 2179 0.2397
75 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1976 0.2394
76 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 314 0.2384
77 ONYCHOMADESIS 988 0.2352
78 MAGNETIC RESONANCE IMAGING ABNORMAL 278 0.2326
79 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2572 0.2322
80 BURSITIS 2789 0.2296
81 JOINT DESTRUCTION 353 0.2269
82 TEMPERATURE REGULATION DISORDER 505 0.2265
83 ONYCHOMYCOSIS 970 0.2209
84 PNEUMOCYSTIS JIROVECII INFECTION 262 0.2192
85 SECONDARY IMMUNODEFICIENCY 264 0.2173
86 JOINT RANGE OF MOTION DECREASED 2894 0.2156
87 EPSTEIN-BARR VIRAEMIA 237 0.2137
88 RELAPSING-REMITTING MULTIPLE SCLEROSIS 181 0.2095
89 WOUND INFECTION 2293 0.2092
90 IRRITABLE BOWEL SYNDROME 4340 0.2022
91 CYSTITIS NONINFECTIVE 270 0.2010
92 COVID-19 PNEUMONIA 2361 0.1998
93 MATERNAL EXPOSURE TIMING UNSPECIFIED 740 0.1968
94 CYTOMEGALOVIRUS INFECTION REACTIVATION 866 0.1958
95 HYPERCHOLESTEROLAEMIA 1845 0.1909
96 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 959 0.1882
97 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 232 0.1859
98 PHARYNGEAL PARAESTHESIA 293 0.1845
99 RHEUMATOID ARTHRITIS 20550 0.1808
100 SERUM SICKNESS 503 0.1803
101 FINGER DEFORMITY 871 0.1796
102 LIVE BIRTH 1473 0.1759
103 NASAL OEDEMA 318 0.1759
104 BLEPHAROSPASM 1091 0.1731
105 ARTHROPATHY 9606 0.1727
106 ASPERGILLUS INFECTION 1115 0.1697
107 POST-ACUTE COVID-19 SYNDROME 207 0.1671
108 TUMOUR LYSIS SYNDROME 1466 0.1665
109 FIBROMYALGIA 4047 0.1663
110 ADJUSTMENT DISORDER 208 0.1600
111 HEPATITIS B 965 0.1600
112 LUPUS NEPHRITIS 299 0.1597
113 AUTOIMMUNE DISORDER 1546 0.1585
114 THERAPEUTIC PRODUCT EFFECT DECREASED 7104 0.1584
115 NAIL DISORDER 1360 0.1553
116 DEMYELINATION 625 0.1524
117 CHRONIC LYMPHOCYTIC LEUKAEMIA 719 0.1514
118 SUSPECTED OFF LABEL USE 679 0.1502
119 ENCEPHALITIS VIRAL 179 0.1470
120 PNEUMOCYSTIS JIROVECII PNEUMONIA 1473 0.1466
121 LIVER INJURY 3586 0.1459
122 SARS-COV-2 TEST POSITIVE 1929 0.1459
123 INFUSION SITE REACTION 435 0.1455
124 TENOSYNOVITIS 400 0.1449
125 PNEUMONIA CYTOMEGALOVIRAL 279 0.1435
126 BLOOD PRESSURE DIASTOLIC DECREASED 1052 0.1424
127 ADENOVIRUS INFECTION 412 0.1419
128 IMPAIRED HEALING 4633 0.1410
129 PULMONARY FIBROSIS 2678 0.1395
130 CYTOMEGALOVIRUS CHORIORETINITIS 269 0.1378
131 SCIATICA 2175 0.1363
132 HEPATITIS E 215 0.1361
133 DRUG INTOLERANCE 13006 0.1345
134 COELIAC DISEASE 1300 0.1324
135 B-CELL LYMPHOMA 449 0.1321
136 AUTOIMMUNE HAEMOLYTIC ANAEMIA 452 0.1317
137 VARICELLA ZOSTER VIRUS INFECTION 273 0.1316
138 LOWER RESPIRATORY TRACT INFECTION 5970 0.1311
139 C-REACTIVE PROTEIN INCREASED 4756 0.1306
140 BK VIRUS INFECTION 440 0.1303
141 FEBRILE NEUTROPENIA 8633 0.1300
142 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 304 0.1296
143 IMMUNE THROMBOCYTOPENIA 593 0.1294
144 IMMUNODEFICIENCY 1922 0.1288
145 NEUTROPENIC SEPSIS 906 0.1267
146 TYPE 2 DIABETES MELLITUS 4270 0.1267
147 HEPATIC ENZYME INCREASED 8610 0.1262
148 BLOOD PRESSURE SYSTOLIC INCREASED 2431 0.1245
149 OBESITY 1978 0.1240
150 CYTOPENIA 1518 0.1239
151 CYTOMEGALOVIRUS INFECTION 2042 0.1227
152 EPSTEIN-BARR VIRUS INFECTION 764 0.1222
153 FOOT DEFORMITY 1350 0.1217
154 TREATMENT FAILURE 10088 0.1216
155 ENTHESOPATHY 189 0.1208
156 CYTOMEGALOVIRUS VIRAEMIA 537 0.1206
157 BLOOD PRESSURE DIASTOLIC INCREASED 551 0.1193
158 LOWER RESPIRATORY TRACT CONGESTION 201 0.1181
159 PNEUMOCYSTIS JIROVECI PNEUMONIA 261 0.1170
160 INTENTIONAL PRODUCT USE ISSUE 10126 0.1155
161 PSORIATIC ARTHROPATHY 4667 0.1149
162 SKIN NECROSIS 593 0.1142
163 COVID-19 20005 0.1139
164 CONTRAST MEDIA ALLERGY 208 0.1135
165 PRODUCT LABEL CONFUSION 660 0.1131
166 PRESCRIBED OVERDOSE 2107 0.1088
167 HAEMATOTOXICITY 1032 0.1085
168 BRONCHOPULMONARY ASPERGILLOSIS 828 0.1067
169 EXOSTOSIS 970 0.1061
170 MUSCLE SPASTICITY 1301 0.1058
171 LYMPHOPENIA 1493 0.1055
172 MULTIPLE SCLEROSIS 5046 0.1054
173 STAPHYLOCOCCAL BACTERAEMIA 458 0.1053
174 WALKING AID USER 693 0.1050
175 SWELLING 9824 0.1049
176 BACK INJURY 1141 0.1048
177 MONOCYTE COUNT INCREASED 373 0.1026
178 JOINT SWELLING 12366 0.1023
179 DISCOMFORT 6237 0.1021
180 HIP ARTHROPLASTY 1558 0.1016
181 MYELODYSPLASTIC SYNDROME 1466 0.1013
182 CYTOMEGALOVIRUS TEST POSITIVE 180 0.1009
183 FINE MOTOR SKILL DYSFUNCTION 292 0.1008
184 GAIT INABILITY 3339 0.0998
185 INTERVERTEBRAL DISCITIS 184 0.0975
186 IMMUNOSUPPRESSION 857 0.0971
187 HUMAN HERPESVIRUS 6 INFECTION 183 0.0967
188 PNEUMONIA VIRAL 305 0.0956
189 CYTOKINE RELEASE SYNDROME 1916 0.0954
190 LYMPHOMA 1471 0.0951
191 BLOOD CHOLESTEROL INCREASED 4410 0.0945
192 MATERNAL EXPOSURE BEFORE PREGNANCY 646 0.0945
193 ORGANISING PNEUMONIA 468 0.0943
194 ORAL PRURITUS 216 0.0940
195 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 198 0.0930
196 THERAPY PARTIAL RESPONDER 1443 0.0924
197 BLOOD PRESSURE FLUCTUATION 2220 0.0924
198 LOWER LIMB FRACTURE 1767 0.0919
199 DRUG TOLERANCE 464 0.0916
200 CUSHINGOID 294 0.0915
201 STOMATITIS 5547 0.0914
202 ESCHERICHIA BACTERAEMIA 214 0.0909
203 OSTEOARTHRITIS 3856 0.0909
204 ALANINE AMINOTRANSFERASE ABNORMAL 191 0.0905
205 FOOD ALLERGY 692 0.0896
206 INFECTION 12969 0.0895
207 SYSTEMIC CANDIDA 222 0.0883
208 APPARENT DEATH 317 0.0879
209 ENTEROCOCCAL INFECTION 425 0.0879
210 BLISTER 4936 0.0878
211 MUSCULOSKELETAL STIFFNESS 7575 0.0864
212 ILL-DEFINED DISORDER 5200 0.0855
213 MATERNAL EXPOSURE DURING PREGNANCY 7624 0.0854
214 INFLAMMATION 4408 0.0853
215 LUPUS-LIKE SYNDROME 774 0.0853
216 SECOND PRIMARY MALIGNANCY 709 0.0852
217 POLYARTHRITIS 448 0.0849
218 CHRONIC GRAFT VERSUS HOST DISEASE 306 0.0847
219 MOBILITY DECREASED 6080 0.0845
220 CYTOMEGALOVIRUS COLITIS 194 0.0843
221 BRONCHITIS CHRONIC 205 0.0839
222 HAEMATOLOGICAL INFECTION 205 0.0837
223 FEBRILE BONE MARROW APLASIA 356 0.0837
224 GLOMERULONEPHRITIS 204 0.0833
225 INFECTION SUSCEPTIBILITY INCREASED 182 0.0831
226 LIVER FUNCTION TEST INCREASED 1777 0.0827
227 PNEUMONIA FUNGAL 325 0.0823
228 PUSTULAR PSORIASIS 281 0.0817
229 LYMPHADENITIS 198 0.0817
230 NIGHT SWEATS 2629 0.0815
231 BACTERIAL SEPSIS 264 0.0810
232 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 215 0.0808
233 KLEBSIELLA INFECTION 404 0.0798
234 BASAL CELL CARCINOMA 1246 0.0798
235 KNEE ARTHROPLASTY 1681 0.0798
236 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 197 0.0796
237 CYSTITIS HAEMORRHAGIC 320 0.0793
238 ORAL HERPES 1545 0.0791
239 THERAPY NON-RESPONDER 3551 0.0789
240 HERPES VIRUS INFECTION 453 0.0786
241 PERONEAL NERVE PALSY 446 0.0784
242 DERMATOMYOSITIS 198 0.0781
243 THROAT IRRITATION 3497 0.0779
244 PRESCRIBED UNDERDOSE 1553 0.0778
245 GASTROINTESTINAL TOXICITY 370 0.0769
246 HYPERCALCAEMIA 944 0.0764
247 PERSONALITY DISORDER 200 0.0763
248 HERPES SIMPLEX 495 0.0761
249 WHEEZING 4503 0.0759
250 OPTIC NEURITIS 684 0.0752
251 AGRANULOCYTOSIS 1398 0.0751
252 BREAST CANCER STAGE II 623 0.0748
253 LYMPHOCYTE COUNT DECREASED 1320 0.0746
254 ESCHERICHIA SEPSIS 215 0.0741
255 PULMONARY TOXICITY 520 0.0735
256 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 551 0.0733
257 NORMAL NEWBORN 399 0.0733
258 SUSPECTED COVID-19 242 0.0733
259 HERPES ZOSTER 4200 0.0730
260 OEDEMA 3951 0.0728
261 BACTERAEMIA 861 0.0725
262 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 429 0.0724
263 ARTHRITIS BACTERIAL 297 0.0723
264 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 199 0.0719
265 MULTIPLE SCLEROSIS RELAPSE 4916 0.0717
266 DISEASE PROGRESSION 8386 0.0708
267 JOINT DISLOCATION 749 0.0708
268 ULCER HAEMORRHAGE 479 0.0707
269 EYE INJURY 214 0.0704
270 RESPIRATORY TRACT INFECTION 1812 0.0695
271 CORONAVIRUS INFECTION 457 0.0690
272 FOETAL DEATH 358 0.0690
273 PSEUDOMONAS INFECTION 589 0.0686
274 LUNG DISORDER 3352 0.0683
275 TRANSPLANT REJECTION 545 0.0680
276 NEUTROPENIA 9217 0.0677
277 PNEUMONIA BACTERIAL 621 0.0676
278 ENCEPHALITIS 466 0.0673
279 BLOOD LACTATE DEHYDROGENASE INCREASED 1066 0.0672
280 ABDOMINAL DISCOMFORT 11150 0.0664
281 RASH VESICULAR 320 0.0661
282 MUCOSAL INFLAMMATION 1726 0.0659
283 UPPER RESPIRATORY TRACT INFECTION 3035 0.0656
284 SINUSITIS 6669 0.0650
285 SPONDYLITIS 236 0.0648
286 MUSCULOSKELETAL PAIN 3390 0.0646
287 ATYPICAL PNEUMONIA 193 0.0645
288 JOINT STIFFNESS 1688 0.0643
289 ALOPECIA 12583 0.0640
290 ACUTE MYELOID LEUKAEMIA 996 0.0638
291 WHITE BLOOD CELL COUNT ABNORMAL 407 0.0637
292 VASCULITIS 742 0.0636
293 SKIN INFECTION 711 0.0633
294 CONGENITAL ANOMALY 490 0.0632
295 SEPTIC SHOCK 2748 0.0631
296 SENSORY LOSS 507 0.0629
297 ULCER 986 0.0619
298 GASTROINTESTINAL DISORDER 5523 0.0616
299 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 586 0.0613
300 STAPHYLOCOCCAL SEPSIS 302 0.0611
301 ESCHERICHIA URINARY TRACT INFECTION 260 0.0611
302 TEMPERATURE INTOLERANCE 630 0.0610
303 BODY TEMPERATURE DECREASED 597 0.0606
304 UROSEPSIS 556 0.0602
305 NASOPHARYNGITIS 11052 0.0599
306 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2868 0.0596
307 RHINOVIRUS INFECTION 231 0.0593
308 GENERAL PHYSICAL HEALTH DETERIORATION 6843 0.0591
309 THROMBOTIC THROMBOCYTOPENIC PURPURA 208 0.0590
310 TASTE DISORDER 1194 0.0588
311 CARDIOTOXICITY 523 0.0586
312 APLASIA PURE RED CELL 200 0.0581
313 VENOOCCLUSIVE LIVER DISEASE 287 0.0581
314 CANDIDA INFECTION 973 0.0576
315 HYPERSENSITIVITY 10641 0.0573
316 HEPATIC CIRRHOSIS 1073 0.0570
317 TRIGEMINAL NEURALGIA 229 0.0569
318 CHILLS 6676 0.0569
319 INTERCEPTED PRODUCT STORAGE ERROR 203 0.0568
320 LEUKOPENIA 2844 0.0568
321 INTERSTITIAL LUNG DISEASE 2743 0.0566
322 THROMBOCYTOPENIA 6297 0.0563
323 ACUTE GRAFT VERSUS HOST DISEASE 256 0.0559
324 SLEEP DISORDER 3944 0.0558
325 SYNOVIAL CYST 257 0.0556
326 PANCYTOPENIA 3105 0.0555
327 LIVER DISORDER 2455 0.0553
328 GRANULOMA 191 0.0551
329 WHEELCHAIR USER 243 0.0546
330 SKIN ULCER 1413 0.0546
331 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 935 0.0545
332 SARCOIDOSIS 259 0.0545
333 BONE MARROW FAILURE 1107 0.0544
334 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1542 0.0544
335 JOINT EFFUSION 375 0.0543
336 RED CELL DISTRIBUTION WIDTH INCREASED 225 0.0541
337 HEMIPARESIS 915 0.0540
338 NEPHROTIC SYNDROME 370 0.0539
339 SEPSIS 5989 0.0536
340 HEPATITIS 1370 0.0535
341 OXYGEN SATURATION DECREASED 3006 0.0534
342 INFLUENZA LIKE ILLNESS 4371 0.0531
343 BLOOD PRESSURE SYSTOLIC DECREASED 241 0.0529
344 OFF LABEL USE 46220 0.0527
345 MYOSITIS 472 0.0525
346 HYPERURICAEMIA 216 0.0525
347 ESCHERICHIA INFECTION 431 0.0523
348 INFLAMMATORY MARKER INCREASED 259 0.0522
349 ADVERSE REACTION 689 0.0519
350 INJURY 3646 0.0518
351 MUSCULAR WEAKNESS 5890 0.0518
352 HYPOAESTHESIA 7733 0.0516
353 NEUTROPHIL COUNT DECREASED 2103 0.0515
354 ARTHRITIS INFECTIVE 239 0.0515
355 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1507 0.0514
356 PNEUMONIA 16561 0.0511
357 BRONCHIECTASIS 343 0.0509
358 GRAFT VERSUS HOST DISEASE 366 0.0508
359 PYREXIA 17520 0.0506
360 VENOUS THROMBOSIS 198 0.0504
361 EAR INFECTION 1339 0.0503
362 VIRAL UPPER RESPIRATORY TRACT INFECTION 239 0.0502
363 PYELONEPHRITIS 432 0.0498
364 GANGRENE 300 0.0497
365 ABDOMINAL ABSCESS 220 0.0497
366 PERIPHERAL SWELLING 7635 0.0495
367 CHRONIC SINUSITIS 186 0.0495
368 HEART RATE DECREASED 1739 0.0495
369 RESPIRATORY RATE INCREASED 435 0.0489
370 CYSTITIS 1556 0.0488
371 KIDNEY TRANSPLANT REJECTION 232 0.0483
372 SENSITIVITY TO WEATHER CHANGE 254 0.0482
373 PERIPHERAL SENSORY NEUROPATHY 282 0.0482
374 MENINGITIS 322 0.0482
375 BODY TEMPERATURE INCREASED 983 0.0481
376 EAR PAIN 935 0.0480
377 PREGNANCY 958 0.0478
378 PRODUCT TEMPERATURE EXCURSION ISSUE 245 0.0476
379 NEURALGIA 1148 0.0472
380 ROAD TRAFFIC ACCIDENT 1963 0.0469
381 EPILEPSY 1432 0.0468
382 EXPOSURE DURING PREGNANCY 2910 0.0468
383 LYMPHADENOPATHY 1653 0.0467
384 THROMBOTIC MICROANGIOPATHY 455 0.0466
385 NODULE 607 0.0465
386 ERYSIPELAS 233 0.0463
387 ADRENAL INSUFFICIENCY 560 0.0461
388 URINARY TRACT INFECTION 7870 0.0461
389 SQUAMOUS CELL CARCINOMA 432 0.0458
390 CONTUSION 4415 0.0458
391 COLITIS MICROSCOPIC 217 0.0458
392 HAEMOLYSIS 352 0.0455
393 DRUG ERUPTION 806 0.0454
394 OSTEOPOROSIS 1856 0.0451
395 POOR VENOUS ACCESS 462 0.0446
396 DEFORMITY 414 0.0442
397 GASTROINTESTINAL INFECTION 397 0.0442
398 BREATH SOUNDS ABNORMAL 218 0.0442
399 DRUG-INDUCED LIVER INJURY 1386 0.0441
400 PLATELET COUNT INCREASED 575 0.0441
401 VAGINAL INFECTION 207 0.0439
402 DISABILITY 865 0.0437
403 DELIRIUM 1512 0.0435
404 DISEASE RECURRENCE 2072 0.0435
405 INTERCEPTED MEDICATION ERROR 201 0.0433
406 NEPHROPATHY TOXIC 484 0.0431
407 HEPATOTOXICITY 959 0.0430
408 PLATELET COUNT ABNORMAL 259 0.0428
409 HYPERTENSION 9056 0.0427
410 LIMB DISCOMFORT 1314 0.0424
411 NECK PAIN 2372 0.0424
412 BRAIN FOG 665 0.0424
413 HYPERTRANSAMINASAEMIA 295 0.0424
414 ENTEROCOLITIS 244 0.0422
415 ARTHRITIS 3318 0.0421
416 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2313 0.0421
417 BACTERIAL INFECTION 782 0.0419
418 MYELOSUPPRESSION 1504 0.0417
419 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2967 0.0417
420 DIVERTICULITIS 1155 0.0416
421 HAEMOLYTIC ANAEMIA 371 0.0414
422 NEUTROPHIL COUNT INCREASED 424 0.0414
423 SINUS CONGESTION 559 0.0413
424 ANAPHYLACTIC REACTION 2275 0.0411
425 CLOSTRIDIUM DIFFICILE COLITIS 436 0.0411
426 ACUTE RESPIRATORY DISTRESS SYNDROME 727 0.0411
427 SPLENOMEGALY 480 0.0409
428 TOOTH INFECTION 540 0.0409
429 INFLUENZA 4558 0.0408
430 APHTHOUS ULCER 315 0.0406
431 PRODUCT USE ISSUE 7628 0.0405
432 DECREASED IMMUNE RESPONSIVENESS 398 0.0405
433 PHARYNGEAL SWELLING 396 0.0404
434 PULMONARY ALVEOLAR HAEMORRHAGE 227 0.0404
435 GAIT DISTURBANCE 7736 0.0404
436 DRY MOUTH 3278 0.0404
437 MUSCULOSKELETAL DISORDER 768 0.0403
438 POLYNEUROPATHY 482 0.0402
439 NO ADVERSE EVENT 7265 0.0401
440 MOTOR DYSFUNCTION 407 0.0399
441 ACUTE HEPATIC FAILURE 545 0.0398
442 MENINGITIS ASEPTIC 179 0.0398
443 SKIN LACERATION 433 0.0398
444 PAIN 24308 0.0395
445 RHINITIS 319 0.0395
446 COORDINATION ABNORMAL 551 0.0395
447 CENTRAL NERVOUS SYSTEM LESION 542 0.0394
448 HEMIPLEGIA 327 0.0393
449 ARTERIAL OCCLUSIVE DISEASE 308 0.0391
450 NEOPLASM 449 0.0390
451 RESPIRATORY DISORDER 1168 0.0390
452 MIGRAINE 3707 0.0388
453 PNEUMONITIS 1056 0.0387
454 ENDOCARDITIS 198 0.0386
455 FUNGAL INFECTION 1286 0.0385
456 PULMONARY MASS 571 0.0383
457 SQUAMOUS CELL CARCINOMA OF SKIN 231 0.0382
458 FATIGUE 29593 0.0380
459 LUNG INFILTRATION 335 0.0379
460 ARTHRALGIA 15703 0.0377
461 THERAPEUTIC RESPONSE DECREASED 2274 0.0375
462 ORAL CANDIDIASIS 487 0.0369
463 INTESTINAL PERFORATION 415 0.0369
464 VITAMIN D DEFICIENCY 359 0.0368
465 CONDITION AGGRAVATED 11190 0.0368
466 TONGUE DISORDER 266 0.0367
467 BLADDER DISORDER 361 0.0363
468 WEIGHT INCREASED 8133 0.0363
469 LEFT VENTRICULAR DYSFUNCTION 243 0.0362
470 APLASTIC ANAEMIA 189 0.0362
471 CARDIOMYOPATHY 533 0.0360
472 WHITE BLOOD CELL COUNT INCREASED 1383 0.0360
473 CLOSTRIDIUM DIFFICILE INFECTION 786 0.0360
474 PHLEBITIS 184 0.0359
475 RASH 15644 0.0359
476 NEUROLOGICAL SYMPTOM 205 0.0358
477 KIDNEY INFECTION 702 0.0357
478 THROAT TIGHTNESS 963 0.0356
479 MALIGNANT MELANOMA 476 0.0355
480 GENERAL SYMPTOM 266 0.0355
481 LUNG INFECTION 550 0.0354
482 ASTHMA 3997 0.0353
483 PULMONARY THROMBOSIS 385 0.0353
484 URTICARIA 5895 0.0352
485 HYDRONEPHROSIS 263 0.0351
486 CONFUSIONAL STATE 5671 0.0351
487 OROPHARYNGEAL PAIN 3219 0.0347
488 RESPIRATORY FAILURE 2521 0.0345
489 EMBOLISM 286 0.0344
490 MASS 479 0.0342
491 BRONCHITIS 2535 0.0342
492 ALANINE AMINOTRANSFERASE INCREASED 2097 0.0341
493 GASTROENTERITIS 491 0.0336
494 STREPTOCOCCAL INFECTION 187 0.0336
495 DRUG RESISTANCE 862 0.0335
496 IMMUNE SYSTEM DISORDER 441 0.0334
497 PRODUCT USE IN UNAPPROVED INDICATION 8236 0.0332
498 ANAL INCONTINENCE 298 0.0331
499 MOUTH ULCERATION 696 0.0330
500 JOINT INJURY 704 0.0329
501 MYASTHENIA GRAVIS 266 0.0329
502 TOOTH FRACTURE 363 0.0329
503 COLITIS 1242 0.0327
504 PARAESTHESIA 5141 0.0326
505 FEELING OF BODY TEMPERATURE CHANGE 190 0.0324
506 DYSPEPSIA 3172 0.0322
507 DEVICE RELATED INFECTION 496 0.0322
508 NEUROTOXICITY 564 0.0322
509 DECUBITUS ULCER 262 0.0321
510 ACUTE PULMONARY OEDEMA 180 0.0320
511 LOCALISED INFECTION 774 0.0320
512 BALANCE DISORDER 2762 0.0319
513 TOOTH ABSCESS 325 0.0319
514 OSTEOMYELITIS 577 0.0318
515 ASPARTATE AMINOTRANSFERASE INCREASED 1689 0.0318
516 CELLULITIS 1592 0.0316
517 WHITE BLOOD CELL COUNT DECREASED 3422 0.0315
518 TENDERNESS 328 0.0314
519 RHINORRHOEA 2017 0.0312
520 MEMORY IMPAIRMENT 4279 0.0311
521 PARALYSIS 445 0.0311
522 PHARYNGITIS 385 0.0310
523 PROTEINURIA 589 0.0309
524 ONYCHOCLASIS 213 0.0309
525 ANAEMIA 5880 0.0308
526 RESPIRATORY TRACT CONGESTION 488 0.0307
527 WEIGHT FLUCTUATION 320 0.0306
528 BLOOD PRESSURE INCREASED 4671 0.0305
529 PLATELET COUNT DECREASED 3221 0.0302
530 SENSORY DISTURBANCE 485 0.0302
531 INFUSION SITE EXTRAVASATION 188 0.0302
532 SYMPTOM RECURRENCE 180 0.0301
533 STAPHYLOCOCCAL INFECTION 992 0.0300
534 ODYNOPHAGIA 179 0.0300
535 CEREBRAL DISORDER 221 0.0298
536 FEELING COLD 831 0.0298
537 TOOTH DISORDER 663 0.0298
538 THERAPEUTIC RESPONSE SHORTENED 980 0.0295
539 HYPOALBUMINAEMIA 229 0.0294
540 AMNESIA 1907 0.0293
541 PAIN IN EXTREMITY 8635 0.0293
542 ASTHENIA 10973 0.0292
543 FEAR OF INJECTION 208 0.0291
544 HEADACHE 18273 0.0291
545 METASTASIS 208 0.0291
546 BLOOD IRON DECREASED 345 0.0290
547 COUGH 8135 0.0290
548 DRUG INEFFECTIVE 38231 0.0290
549 ACUTE RESPIRATORY FAILURE 557 0.0289
550 SPINAL DISORDER 274 0.0289
551 PRODUCT SUPPLY ISSUE 206 0.0288
552 PULMONARY HAEMORRHAGE 225 0.0287
553 HAEMOGLOBIN ABNORMAL 185 0.0287
554 DRUG EFFECT LESS THAN EXPECTED 424 0.0286
555 VITAMIN D DECREASED 244 0.0285
556 INTERVERTEBRAL DISC DEGENERATION 264 0.0285
557 EYE INFECTION 321 0.0284
558 FEELING HOT 1742 0.0284
559 MICTURITION URGENCY 324 0.0283
560 AFFECT LABILITY 271 0.0281
561 URINARY INCONTINENCE 832 0.0281
562 ENTERITIS 179 0.0279
563 HEART RATE INCREASED 2770 0.0279
564 FACIAL PARALYSIS 237 0.0278
565 GENERALISED OEDEMA 344 0.0278
566 RESPIRATORY SYNCYTIAL VIRUS INFECTION 241 0.0277
567 ATAXIA 328 0.0276
568 ATRIAL FIBRILLATION 2689 0.0276
569 VIRAL INFECTION 912 0.0274
570 POSTOPERATIVE WOUND INFECTION 185 0.0274
571 TRANSAMINASES INCREASED 609 0.0274
572 NERVE INJURY 304 0.0273
573 SNEEZING 611 0.0272
574 NERVE COMPRESSION 251 0.0272
575 NEUROPATHY PERIPHERAL 2584 0.0271
576 POST-TRAUMATIC STRESS DISORDER 182 0.0271
577 APPENDICITIS 253 0.0271
578 ABSCESS 432 0.0270
579 PRODUCTIVE COUGH 1290 0.0270
580 COGNITIVE DISORDER 1260 0.0270
581 DISSEMINATED INTRAVASCULAR COAGULATION 379 0.0269
582 OROPHARYNGEAL DISCOMFORT 239 0.0264
583 CATARACT 1573 0.0264
584 DEEP VEIN THROMBOSIS 1710 0.0263
585 PLEURAL EFFUSION 1598 0.0262
586 NASAL CONGESTION 1543 0.0262
587 HYPOPHOSPHATAEMIA 194 0.0262
588 DENTAL CARIES 289 0.0261
589 RASH MACULO-PAPULAR 581 0.0261
590 GASTROOESOPHAGEAL REFLUX DISEASE 2100 0.0261
591 CHEST PAIN 4813 0.0260
592 PETECHIAE 271 0.0259
593 INCONTINENCE 273 0.0258
594 NEPHROLITHIASIS 1184 0.0258
595 PULMONARY EMBOLISM 2437 0.0256
596 BLOOD DISORDER 205 0.0256
597 FLUID RETENTION 1292 0.0254
598 LIGAMENT SPRAIN 251 0.0254
599 HYPOKALAEMIA 1171 0.0253
600 MALAISE 11123 0.0253
601 SKIN REACTION 356 0.0252
602 INTERVERTEBRAL DISC PROTRUSION 552 0.0252
603 MUSCLE TIGHTNESS 408 0.0252
604 HEPATIC CYTOLYSIS 321 0.0252
605 MUSCLE SPASMS 4599 0.0250
606 HEPATIC FAILURE 755 0.0250
607 NEOPLASM PROGRESSION 867 0.0249
608 APHONIA 347 0.0248
609 BACK DISORDER 402 0.0247
610 ATELECTASIS 238 0.0246
611 ILEUS 306 0.0246
612 BLOOD CREATININE INCREASED 1595 0.0244
613 MYOPATHY 211 0.0244
614 EJECTION FRACTION DECREASED 378 0.0243
615 DRY THROAT 247 0.0243
616 DIPLOPIA 629 0.0242
617 MOVEMENT DISORDER 777 0.0242
618 PULMONARY CONGESTION 319 0.0242
619 SPINAL OSTEOARTHRITIS 212 0.0241
620 GASTROENTERITIS VIRAL 435 0.0241
621 INJECTION SITE EXTRAVASATION 297 0.0240
622 LEUKOCYTOSIS 434 0.0240
623 EAR DISCOMFORT 246 0.0239
624 CHOLECYSTITIS 285 0.0239
625 HEPATIC STEATOSIS 444 0.0238
626 SPUTUM DISCOLOURED 226 0.0238
627 ATRIAL FLUTTER 189 0.0237
628 RASH PRURITIC 1279 0.0236
629 ILLNESS 2428 0.0235
630 REBOUND EFFECT 266 0.0235
631 GASTRIC DISORDER 806 0.0235
632 APHASIA 709 0.0235
633 HYPOXIA 826 0.0234
634 PURPURA 205 0.0231
635 ADVERSE EVENT 2132 0.0231
636 ABDOMINAL PAIN UPPER 4740 0.0230
637 WEIGHT DECREASED 6420 0.0230
638 PRURITUS 8823 0.0229
639 TENDONITIS 355 0.0229
640 MYOCARDITIS 262 0.0228
641 RASH ERYTHEMATOUS 1092 0.0228
642 ADVERSE DRUG REACTION 2047 0.0228
643 LOW BIRTH WEIGHT BABY 181 0.0228
644 SINUS DISORDER 449 0.0226
645 VOMITING 10652 0.0226
646 ANGINA PECTORIS 649 0.0226
647 DYSPNOEA 12774 0.0225
648 ENCEPHALOPATHY 553 0.0225
649 BLOOD TEST ABNORMAL 316 0.0225
650 INSOMNIA 5989 0.0225
651 RESTLESS LEGS SYNDROME 406 0.0223
652 HYPOKINESIA 321 0.0221
653 DERMATITIS ALLERGIC 277 0.0220
654 DYSPHAGIA 2089 0.0220
655 HAEMATOCRIT DECREASED 436 0.0220
656 FALL 7270 0.0218
657 BACK PAIN 5061 0.0218
658 HAEMOGLOBIN DECREASED 2234 0.0217
659 DECREASED APPETITE 5048 0.0217
660 SKIN LESION 593 0.0216
661 RESPIRATORY DISTRESS 596 0.0216
662 SKIN HAEMORRHAGE 319 0.0215
663 TOOTHACHE 389 0.0215
664 DRUG USE DISORDER 179 0.0213
665 DYSARTHRIA 798 0.0212
666 PNEUMOTHORAX 336 0.0212
667 DEPRESSION 4797 0.0211
668 RED BLOOD CELL COUNT DECREASED 597 0.0209
669 OSTEOPENIA 315 0.0207
670 HYPOTENSION 4148 0.0207
671 MEDICATION ERROR 1146 0.0206
672 RENAL IMPAIRMENT 1727 0.0205
673 IMPAIRED GASTRIC EMPTYING 280 0.0205
674 CONJUNCTIVITIS 381 0.0205
675 EYE DISORDER 671 0.0204
676 OEDEMA PERIPHERAL 2482 0.0203
677 SEASONAL ALLERGY 287 0.0203
678 TACHYCARDIA 1801 0.0203
679 FOOT FRACTURE 384 0.0202
680 VISUAL IMPAIRMENT 2491 0.0201
681 GINGIVAL BLEEDING 274 0.0200
682 CHEST DISCOMFORT 2050 0.0200
683 HYPERTENSIVE CRISIS 222 0.0199
684 END STAGE RENAL DISEASE 363 0.0199
685 MALNUTRITION 222 0.0198
686 CYST 246 0.0198
687 HYPOCALCAEMIA 375 0.0198
688 NAUSEA 15657 0.0198
689 LABORATORY TEST ABNORMAL 582 0.0197
690 SPINAL PAIN 231 0.0197
691 UVEITIS 267 0.0197
692 HAEMORRHAGE INTRACRANIAL 294 0.0196
693 DYSSTASIA 574 0.0196
694 INJECTION SITE REACTION 1352 0.0196
695 IRON DEFICIENCY ANAEMIA 181 0.0196
696 THROMBOSIS 1571 0.0195
697 GAMMA-GLUTAMYLTRANSFERASE INCREASED 429 0.0193
698 CARDIAC FAILURE 1553 0.0193
699 ACUTE KIDNEY INJURY 2957 0.0193
700 SLUGGISHNESS 197 0.0193
701 ABDOMINAL PAIN 4482 0.0192
702 ANKLE FRACTURE 297 0.0192
703 SLEEP APNOEA SYNDROME 366 0.0192
704 NEPHROPATHY 179 0.0192
705 HYPOTHYROIDISM 612 0.0191
706 GASTRIC ULCER 364 0.0191
707 PHOTOSENSITIVITY REACTION 316 0.0191
708 GLOMERULAR FILTRATION RATE DECREASED 235 0.0191
709 BRAIN OEDEMA 240 0.0190
710 NEOPLASM MALIGNANT 1265 0.0189
711 ASCITES 553 0.0188
712 PERIPHERAL COLDNESS 257 0.0187
713 BLOOD ALKALINE PHOSPHATASE INCREASED 464 0.0187
714 CARPAL TUNNEL SYNDROME 261 0.0186
715 HYPERBILIRUBINAEMIA 193 0.0186
716 LIMB INJURY 504 0.0185
717 LIVER FUNCTION TEST ABNORMAL 539 0.0185
718 BLOOD URINE PRESENT 351 0.0185
719 GLAUCOMA 356 0.0185
720 ORAL DISCOMFORT 255 0.0183
721 NERVOUS SYSTEM DISORDER 572 0.0183
722 WRIST FRACTURE 219 0.0183
723 DIARRHOEA 11765 0.0182
724 FREQUENT BOWEL MOVEMENTS 490 0.0181
725 BEDRIDDEN 238 0.0181
726 THYROID DISORDER 279 0.0181
727 HEPATITIS C 218 0.0180
728 DIABETES MELLITUS 1372 0.0180
729 FLUSHING 1828 0.0180
730 HEAD DISCOMFORT 317 0.0179
731 BLOOD BILIRUBIN INCREASED 481 0.0178
732 HYPERHIDROSIS 2293 0.0178
733 RIB FRACTURE 366 0.0178
734 PNEUMONIA ASPIRATION 444 0.0178
735 ERYTHEMA 3636 0.0177
736 DYSPNOEA EXERTIONAL 665 0.0176
737 HYPOAESTHESIA ORAL 266 0.0176
738 HAEMATURIA 604 0.0176
739 PARAESTHESIA ORAL 254 0.0176
740 ELECTROLYTE IMBALANCE 204 0.0175
741 DIZZINESS 8745 0.0175
742 BLINDNESS 713 0.0175
743 GASTRITIS 459 0.0174
744 PREMATURE DELIVERY 277 0.0174
745 EATING DISORDER 370 0.0174
746 VERTIGO 1057 0.0173
747 PERITONITIS 359 0.0173
748 HERNIA 335 0.0173
749 MALIGNANT NEOPLASM PROGRESSION 1774 0.0173
750 HEPATIC FUNCTION ABNORMAL 646 0.0173
751 SMALL INTESTINAL OBSTRUCTION 212 0.0172
752 ANKYLOSING SPONDYLITIS 227 0.0172
753 MULTI-ORGAN FAILURE 297 0.0172
754 HYPERGLYCAEMIA 624 0.0171
755 SYNCOPE 1705 0.0170
756 PHARYNGITIS STREPTOCOCCAL 184 0.0170
757 CARDIOGENIC SHOCK 243 0.0169
758 IMPAIRED WORK ABILITY 361 0.0169
759 PANCREATITIS 891 0.0168
760 EOSINOPHILIA 295 0.0168
761 MUSCLE TWITCHING 388 0.0168
762 OESOPHAGITIS 183 0.0167
763 ACCIDENT 200 0.0167
764 BRONCHOSPASM 238 0.0167
765 BONE PAIN 976 0.0166
766 BLINDNESS UNILATERAL 235 0.0166
767 ORAL PAIN 372 0.0166
768 UNDERDOSE 1207 0.0165
769 POOR QUALITY SLEEP 352 0.0163
770 PERICARDIAL EFFUSION 378 0.0163
771 TREMOR 2705 0.0163
772 URINARY RETENTION 540 0.0162
773 MUSCLE ATROPHY 205 0.0162
774 MUSCULOSKELETAL CHEST PAIN 250 0.0161
775 CHOLESTASIS 310 0.0161
776 FOETAL EXPOSURE DURING PREGNANCY 1312 0.0161
777 ABDOMINAL DISTENSION 1683 0.0161
778 PHOTOPHOBIA 302 0.0160
779 HIATUS HERNIA 207 0.0160
780 DERMATITIS 331 0.0158
781 MYALGIA 2683 0.0158
782 SPINAL FRACTURE 316 0.0158
783 BONE DISORDER 287 0.0157
784 PAIN IN JAW 446 0.0157
785 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 267 0.0157
786 HAEMATOMA 405 0.0156
787 SUBDURAL HAEMATOMA 223 0.0156
788 ROTATOR CUFF SYNDROME 200 0.0156
789 HEPATOCELLULAR INJURY 220 0.0155
790 RENAL FAILURE 2056 0.0155
791 RECTAL HAEMORRHAGE 664 0.0154
792 ARRHYTHMIA 729 0.0154
793 TACHYPNOEA 209 0.0154
794 PSORIASIS 2004 0.0153
795 COLD SWEAT 270 0.0153
796 MUSCULOSKELETAL DISCOMFORT 263 0.0153
797 PREMATURE BABY 459 0.0152
798 COLON CANCER 227 0.0152
799 DYSPHONIA 886 0.0151
800 SECRETION DISCHARGE 189 0.0151
801 BURNING SENSATION 1056 0.0150
802 BLOOD PRESSURE DECREASED 1000 0.0150
803 CHOLELITHIASIS 493 0.0150
804 DEAFNESS 393 0.0150
805 GOUT 269 0.0150
806 HEART RATE IRREGULAR 337 0.0149
807 SKIN CANCER 320 0.0148
808 HYPERSOMNIA 426 0.0148
809 INCORRECT DOSE ADMINISTERED BY DEVICE 389 0.0148
810 SPEECH DISORDER 777 0.0148
811 PALPITATIONS 1723 0.0147
812 FEELING ABNORMAL 3513 0.0146
813 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2631 0.0146
814 ACUTE MYOCARDIAL INFARCTION 430 0.0146
815 SINUS TACHYCARDIA 206 0.0145
816 SKIN DISORDER 483 0.0145
817 ANXIETY 4081 0.0143
818 ANAPHYLACTIC SHOCK 369 0.0143
819 ABORTION SPONTANEOUS 570 0.0142
820 COLITIS ULCERATIVE 635 0.0142
821 HAEMORRHAGE 1484 0.0142
822 DYSURIA 518 0.0141
823 CARDIOVASCULAR DISORDER 356 0.0140
824 LETHARGY 794 0.0138
825 HOT FLUSH 1040 0.0138
826 FEEDING DISORDER 279 0.0137
827 HYPOMAGNESAEMIA 191 0.0137
828 LOSS OF CONSCIOUSNESS 1753 0.0137
829 GALLBLADDER DISORDER 244 0.0137
830 PULMONARY OEDEMA 612 0.0137
831 PHARYNGEAL OEDEMA 210 0.0136
832 BLOOD PRESSURE ABNORMAL 269 0.0135
833 COAGULOPATHY 225 0.0135
834 BLOOD UREA INCREASED 226 0.0135
835 HYPONATRAEMIA 758 0.0134
836 ISCHAEMIC STROKE 239 0.0134
837 PRESYNCOPE 325 0.0134
838 HYPERKALAEMIA 466 0.0133
839 RENAL DISORDER 618 0.0132
840 PALLOR 359 0.0132
841 SEIZURE 1520 0.0131
842 CONSTIPATION 2859 0.0131
843 DRY EYE 653 0.0131
844 INTENTIONAL DOSE OMISSION 372 0.0130
845 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 668 0.0128
846 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 329 0.0128
847 PULMONARY HYPERTENSION 265 0.0127
848 UPPER LIMB FRACTURE 253 0.0127
849 HAEMOPTYSIS 354 0.0127
850 MENTAL IMPAIRMENT 306 0.0126
851 TOXIC EPIDERMAL NECROLYSIS 190 0.0125
852 BLOOD POTASSIUM DECREASED 376 0.0125
853 DEPRESSED MOOD 655 0.0124
854 TINNITUS 562 0.0122
855 DEHYDRATION 1630 0.0122
856 SCAR 208 0.0121
857 POLLAKIURIA 501 0.0120
858 SOMNOLENCE 2403 0.0119
859 TOOTH LOSS 246 0.0119
860 PRODUCT PRESCRIBING ERROR 281 0.0118
861 CEREBRAL INFARCTION 288 0.0118
862 EYE PAIN 664 0.0118
863 GASTROINTESTINAL HAEMORRHAGE 971 0.0116
864 DISTURBANCE IN ATTENTION 624 0.0116
865 MENTAL STATUS CHANGES 318 0.0114
866 TUBULOINTERSTITIAL NEPHRITIS 214 0.0114
867 HAEMORRHOIDS 222 0.0114
868 EPISTAXIS 848 0.0113
869 LUNG NEOPLASM MALIGNANT 465 0.0113
870 SHOCK 260 0.0113
871 FEMUR FRACTURE 350 0.0113
872 DIABETES MELLITUS INADEQUATE CONTROL 199 0.0112
873 JAUNDICE 302 0.0112
874 BREAST CANCER 1045 0.0112
875 VISION BLURRED 1522 0.0111
876 PANCREATITIS ACUTE 247 0.0110
877 UPPER GASTROINTESTINAL HAEMORRHAGE 184 0.0109
878 PRODUCT PRESCRIBING ISSUE 237 0.0109
879 CARDIAC ARREST 897 0.0109
880 CARDIAC DISORDER 1012 0.0108
881 FRACTURE 203 0.0107
882 BLOOD SODIUM DECREASED 202 0.0107
883 PANIC ATTACK 389 0.0107
884 RETCHING 227 0.0106
885 CEREBRAL HAEMORRHAGE 380 0.0106
886 HIP FRACTURE 338 0.0105
887 HEAD INJURY 332 0.0105
888 HYPOPHAGIA 268 0.0105
889 DEATH 9026 0.0105
890 SWELLING FACE 681 0.0104
891 BRADYCARDIA 552 0.0104
892 OSTEONECROSIS 340 0.0103
893 TOXICITY TO VARIOUS AGENTS 1716 0.0102
894 PSYCHOTIC DISORDER 297 0.0100
895 SKIN DISCOLOURATION 459 0.0100
896 INTESTINAL OBSTRUCTION 372 0.0099
897 DRUG EFFECT INCOMPLETE 356 0.0098
898 MELAENA 215 0.0098
899 PRODUCT STORAGE ERROR 846 0.0097
900 INTENTIONAL PRODUCT MISUSE 844 0.0096
901 LACRIMATION INCREASED 289 0.0096
902 MENTAL DISORDER 416 0.0095
903 FEELING JITTERY 182 0.0095
904 ABDOMINAL PAIN LOWER 241 0.0095
905 PRODUCT AVAILABILITY ISSUE 217 0.0095
906 ACCIDENTAL EXPOSURE TO PRODUCT 981 0.0095
907 PRODUCT ADMINISTRATION ERROR 192 0.0095
908 MOOD SWINGS 302 0.0095
909 INJECTION SITE BRUISING 752 0.0094
910 SWOLLEN TONGUE 292 0.0093
911 DRUG EFFECT DECREASED 502 0.0093
912 DEVICE MALFUNCTION 650 0.0092
913 STEVENS-JOHNSON SYNDROME 204 0.0092
914 ANGIOEDEMA 405 0.0091
915 NEEDLE ISSUE 265 0.0091
916 CEREBROVASCULAR ACCIDENT 1512 0.0089
917 EMOTIONAL DISORDER 275 0.0089
918 CRYING 321 0.0088
919 AGEUSIA 220 0.0088
920 RASH MACULAR 307 0.0088
921 MYOCARDIAL INFARCTION 1530 0.0088
922 HYPOACUSIS 377 0.0087
923 CORONARY ARTERY DISEASE 265 0.0087
924 CARDIAC FAILURE CONGESTIVE 690 0.0086
925 ECZEMA 437 0.0083
926 NERVOUSNESS 425 0.0081
927 TRANSIENT ISCHAEMIC ATTACK 274 0.0081
928 EYE SWELLING 302 0.0081
929 TREATMENT NONCOMPLIANCE 436 0.0080
930 EYE PRURITUS 267 0.0079
931 RENAL FAILURE ACUTE 333 0.0078
932 RESTLESSNESS 283 0.0077
933 COMA 366 0.0077
934 BONE DENSITY DECREASED 240 0.0077
935 PRODUCT QUALITY ISSUE 1025 0.0075
936 HAEMATOCHEZIA 408 0.0074
937 DISORIENTATION 290 0.0073
938 UNEVALUABLE EVENT 548 0.0072
939 SKIN EXFOLIATION 605 0.0072
940 DEMENTIA 199 0.0071
941 DRUG INTERACTION 1107 0.0070
942 BLOOD CREATINE PHOSPHOKINASE INCREASED 200 0.0069
943 MOOD ALTERED 188 0.0069
944 LIP SWELLING 228 0.0068
945 ACNE 515 0.0068
946 PRODUCT DOSE OMISSION ISSUE 1900 0.0065
947 VISUAL ACUITY REDUCED 213 0.0064
948 OCULAR HYPERAEMIA 299 0.0063
949 LACTIC ACIDOSIS 204 0.0063
950 DEVICE LEAKAGE 271 0.0062
951 DEPRESSED LEVEL OF CONSCIOUSNESS 247 0.0062
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 210 0.0062
953 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 284 0.0061
954 THERAPY CESSATION 311 0.0061
955 AGITATION 440 0.0060
956 INJECTION SITE HAEMORRHAGE 475 0.0059
957 DYSKINESIA 241 0.0059
958 OVERDOSE 1277 0.0059
959 METABOLIC ACIDOSIS 188 0.0059
960 HOSPITALISATION 901 0.0059
961 BLOOD GLUCOSE INCREASED 1094 0.0058
962 CHRONIC KIDNEY DISEASE 439 0.0058
963 PROSTATE CANCER 460 0.0057
964 CARDIO-RESPIRATORY ARREST 231 0.0055
965 HYPOGLYCAEMIA 267 0.0055
966 HALLUCINATION 413 0.0055
967 DYSGEUSIA 402 0.0054
968 DRUG DOSE OMISSION BY DEVICE 423 0.0054
969 INJECTION SITE PAIN 1514 0.0049
970 IRRITABILITY 294 0.0049
971 DRY SKIN 622 0.0047
972 THERAPEUTIC RESPONSE UNEXPECTED 203 0.0045
973 THERAPY INTERRUPTED 313 0.0044
974 VAGINAL HAEMORRHAGE 185 0.0043
975 FLATULENCE 240 0.0042
976 BLOOD GLUCOSE DECREASED 203 0.0042
977 EYE IRRITATION 243 0.0042
978 SUICIDAL IDEATION 368 0.0040
979 INJECTION SITE SWELLING 302 0.0039
980 INJECTION SITE PRURITUS 263 0.0039
981 INJECTION SITE ERYTHEMA 483 0.0039
982 DEVICE ISSUE 325 0.0036
983 INCORRECT DOSE ADMINISTERED 795 0.0035
984 SURGERY 202 0.0034
985 SKIN BURNING SENSATION 243 0.0034
986 DRUG DEPENDENCE 373 0.0023
987 EMOTIONAL DISTRESS 263 0.0022
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 409 0.0020